Peter Traber
Director/Miembro de la Junta en Baylor College of Medicine .
Fortuna: 110 791 $ al 30/04/2024
Cargos activos de Peter Traber
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Baylor College of Medicine | Director/Miembro de la Junta | 01/01/2008 | - |
| Director Ejecutivo | 01/01/2003 | 01/01/2008 |
Historial de carrera de Peter Traber
Antiguos cargos conocidos de Peter Traber.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 30/03/2020 | 13/11/2023 |
| Alacrita Consulting Ltd. | Corporate Officer/Principal | 01/07/2018 | 01/08/2020 |
| GALECTIN THERAPEUTICS INC. | Director/Miembro de la Junta | 12/02/2009 | 14/12/2017 |
| Director Ejecutivo | 23/03/2011 | 06/07/2018 | |
| Director Técnico/Científico/I+D | 18/06/2010 | 06/07/2018 | |
| Contacto de Relaciones con Inversores | 12/02/2009 | - | |
| Presidente | 23/03/2011 | 06/07/2018 | |
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Director/Miembro de la Junta | - | 03/08/2007 |
| GSK PLC | Director Técnico/Científico/I+D | 01/01/2000 | 01/01/2003 |
| Consejero General | 01/01/2000 | 01/01/2003 | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Director Técnico/Científico/I+D | - | - |
| University of Pennsylvania Medical Center | Corporate Officer/Principal | - | - |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Director/Miembro de la Junta | 22/01/2015 | - |
| Independent Dir/Board Member | 22/01/2015 | - | |
| ░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formación de Peter Traber.
| University of Michigan | Undergraduate Degree |
| The Wayne State University School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 13 |
| Reino Unido | 3 |
Operativa
| Director/Board Member | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| President | 3 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 5 |
| Producer Manufacturing | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| GALECTIN THERAPEUTICS INC. | Health Technology |
| GSK PLC | Health Technology |
| Empresas privadas | 8 |
|---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
Noble International Ltd.
 Noble International Ltd. Auto Parts: OEMProducer Manufacturing Noble International Ltd. manufactures and supplies automotive components, provides laser welding and cutting services. The company is headquartered in Troy, MI. | Producer Manufacturing |
| Terrasep LLC | |
The University of Pennsylvania Health System
 The University of Pennsylvania Health System Miscellaneous Commercial ServicesCommercial Services The University of Pennsylvania Health System provides general patient care as well as medical education and research services. The company was founded in 1874 and is headquartered in Philadelphia, PA. | Commercial Services |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
| Alacrita Consulting Ltd. | |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Peter Traber
- Experiencia
